{"id":61877,"date":"2025-09-17T04:03:49","date_gmt":"2025-09-17T02:03:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/"},"modified":"2025-09-17T04:03:49","modified_gmt":"2025-09-17T02:03:49","slug":"celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/","title":{"rendered":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Strengthen the PFS CMO business through a long-term partnership with global syringe leader BD<\/b><\/li>\n<li>\n<b>Expand the global customer network by leveraging the BD&amp;CMO Partnership Program<\/b><\/li>\n<li>\n<b>Triple production capacity of the Cheongju plant by 2030, up from the current annual output of 16 million syringes<\/b><\/li>\n<\/ul>\n<p>CHEONGJU, South Korea&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/AutoInjector?src=hash\" target=\"_blank\">#AutoInjector<\/a>&#8212;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.celltrionph.com%2Fen-us%2Fhome%2Findex&amp;esheet=54323876&amp;newsitemid=20250914960476&amp;lan=en-US&amp;anchor=Celltrion+Pharm&amp;index=1&amp;md5=35f4264d5124c9daae377610e64ef751\" rel=\"nofollow\" shape=\"rect\">Celltrion Pharm<\/a> (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a multinational syringe manufacturer, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bd.com%2Ffr-fr&amp;esheet=54323876&amp;newsitemid=20250914960476&amp;lan=en-US&amp;anchor=Becton+Dickinson+France+S.A.S.&amp;index=2&amp;md5=73d5f05e1cf7fa780ca8576e3920ee77\" rel=\"nofollow\" shape=\"rect\">Becton Dickinson France S.A.S.<\/a> (BD), and its Korean branch <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bd.com%2Fko-kr&amp;esheet=54323876&amp;newsitemid=20250914960476&amp;lan=en-US&amp;anchor=BD+Korea&amp;index=3&amp;md5=71932441e364f8c49d3655259c131ed8\" rel=\"nofollow\" shape=\"rect\">BD Korea<\/a>. The signing ceremony took place at Celltrion Pharm\u2019s research center in Songdo, Incheon, with its President Yoo Young-ho in attendance alongside key officials from BD and BD Korea.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/5\/BD_Celltrion_Pharma_trilateral.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/22\/BD_Celltrion_Pharma_trilateral.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/5\/BD_Celltrion_Pharma_trilateral.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/21\/BD_Celltrion_Pharma_trilateral.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2579885\/5\/Celltrion_Pharm_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2579885\/22\/Celltrion_Pharm_logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2579885\/5\/Celltrion_Pharm_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2579885\/21\/Celltrion_Pharm_logo.jpg\"><\/a><\/p>\n<p>\nUnder the three-way agreement, Celltrion Pharm will establish a long-term partnership with BD and implement joint strategies to secure global clients. By combining its advanced contract manufacturing (CMO) capabilities with BD\u2019s extensive customer network, Celltrion Pharm aims to accelerate the growth of its prefilled syringe (PFS) CMO business for pharmaceutical companies in both domestic and international markets.<\/p>\n<p>\nNotably, Celltrion Pharm will leverage the BD&amp;CMO Partnership Program to promote its PFS CMO capabilities to BD\u2019s key global clients. Acting as a networking platform, the program connects BD\u2019s worldwide client base with qualified CMO companies and recommends appropriate partners based on client needs, thereby fostering new business collaborations.<\/p>\n<p>\nTo address rising demand for PFS production, Celltrion Pharm is expanding its production line at the Cheongju plant. With an annual production capacity of up to 16 million syringes, the three-story, 2,315\u33a1 plant currently operates a PFS line capable of handling the entire process, from drug substance formulation to filling, Visual inspection, assembly, labeling, and packaging. The new production base will be built on 13,554\u33a1 of available land by 2030. Once operational, the new facility is expected to triple the total PFS production capacity.<\/p>\n<p>\nThe Cheongju plant, which obtained the global GMP certification in 2023, manufactures Celltrion\u2019s autoimmune disease treatments <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcelltrionhealthcare.ca%2Fproducts%2Fproduct%2F%3Fpkey%3D59&amp;esheet=54323876&amp;newsitemid=20250914960476&amp;lan=en-US&amp;anchor=Remsima+SC&amp;index=4&amp;md5=1c492396e076abf2883c2bb8bd7a04bc\" rel=\"nofollow\" shape=\"rect\">Remsima SC<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.yuflyma.com%2F&amp;esheet=54323876&amp;newsitemid=20250914960476&amp;lan=en-US&amp;anchor=Yuflyma&amp;index=5&amp;md5=6bbe0fb3f666d40fd969602c6518386e\" rel=\"nofollow\" shape=\"rect\">Yuflyma<\/a>. It is also equipped to produce three types of PFS formulations: Auto-Injector (AI), Prefilled Syringe (PFS), and Prefilled Syringe-S (Safety Device). A key advantage is its ability to produce both the high-demand Auto-Injector and the Prefilled Syringe-S type simultaneously.<\/p>\n<p>\nCelltrion Pharm views the agreement as a key milestone in expanding its PFS CMO business globally by leveraging BD\u2019s extensive customer network. Building on its differentiated PFS production capabilities, the company will continue to strengthen the competitiveness of its global CMO operations and drive the rapid acquisition of new customers.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nCelltrion Pharm, Inc.<br \/>\n<br \/>For PR inquiries<br \/>\n<br \/>Si Young, Choi<br \/>\n<br \/>+82-70-8675-7681<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;&#x3a;s&#105;&#x79;o&#117;&#x6e;&#x67;&#46;&#99;&#x68;o&#105;&#x40;&#x63;e&#108;&#x6c;&#x74;&#114;&#x69;&#x6f;n&#112;&#x68;&#x2e;c&#111;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#115;&#x69;y&#x6f;&#x75;&#110;&#x67;&#46;&#99;&#x68;&#111;&#x69;&#64;&#99;&#x65;l&#x6c;t&#114;&#x69;o&#x6e;&#x70;&#104;&#x2e;c&#111;&#x6d;<\/a><\/p>\n<p>\nFor PFS CMO Business inquiries<br \/>\n<br \/>Yu Ju Han<br \/>\n<br \/>+82-70-8675-7690<br \/>\n<br \/><a target=\"_blank\" href=\"ma&#105;&#108;&#116;&#x6f;&#x3a;&#x79;&#x75;&#x6a;u&#46;&#104;&#97;&#110;&#x40;&#x63;&#x65;&#x6c;&#x6c;tr&#105;&#111;&#110;&#x70;&#x68;&#x2e;&#x63;&#x6f;m\" rel=\"nofollow\" shape=\"rect\">&#x79;&#117;&#x6a;&#x75;&#46;&#x68;&#97;n&#x40;&#99;e&#x6c;&#108;&#x74;&#x72;i&#x6f;&#110;p&#x68;&#46;c&#x6f;&#109;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Strengthen the PFS CMO business through a long-term partnership with global syringe leader BD Expand the global customer network by leveraging the BD&amp;CMO Partnership Program Triple production capacity of the Cheongju plant by 2030, up from the current annual output of 16 million syringes CHEONGJU, South Korea&#8211;(BUSINESS WIRE)&#8211;#AutoInjector&#8212;Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61877","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Strengthen the PFS CMO business through a long-term partnership with global syringe leader BD Expand the global customer network by leveraging the BD&amp;CMO Partnership Program Triple production capacity of the Cheongju plant by 2030, up from the current annual output of 16 million syringes CHEONGJU, South Korea&#8211;(BUSINESS WIRE)&#8211;#AutoInjector&#8212;Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-17T02:03:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/22\/BD_Celltrion_Pharma_trilateral.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business\",\"datePublished\":\"2025-09-17T02:03:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/\"},\"wordCount\":467,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250914960476\\\/en\\\/2581608\\\/22\\\/BD_Celltrion_Pharma_trilateral.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/\",\"name\":\"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250914960476\\\/en\\\/2581608\\\/22\\\/BD_Celltrion_Pharma_trilateral.jpg\",\"datePublished\":\"2025-09-17T02:03:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250914960476\\\/en\\\/2581608\\\/22\\\/BD_Celltrion_Pharma_trilateral.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250914960476\\\/en\\\/2581608\\\/22\\\/BD_Celltrion_Pharma_trilateral.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/","og_locale":"en_US","og_type":"article","og_title":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - Pharma Trend","og_description":"Strengthen the PFS CMO business through a long-term partnership with global syringe leader BD Expand the global customer network by leveraging the BD&amp;CMO Partnership Program Triple production capacity of the Cheongju plant by 2030, up from the current annual output of 16 million syringes CHEONGJU, South Korea&#8211;(BUSINESS WIRE)&#8211;#AutoInjector&#8212;Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-17T02:03:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/22\/BD_Celltrion_Pharma_trilateral.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business","datePublished":"2025-09-17T02:03:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/"},"wordCount":467,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/22\/BD_Celltrion_Pharma_trilateral.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/","url":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/","name":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/22\/BD_Celltrion_Pharma_trilateral.jpg","datePublished":"2025-09-17T02:03:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/22\/BD_Celltrion_Pharma_trilateral.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250914960476\/en\/2581608\/22\/BD_Celltrion_Pharma_trilateral.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/celltrion-pharm-signs-strategic-trilateral-agreement-with-becton-dickinson-and-bd-korea-to-accelerate-global-pfs-cmo-business\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61877"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61877\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}